Literature DB >> 31678895

Associations of Vitamin D Receptor Single Nucleotide Polymorphisms with Susceptibility to Systemic Sclerosis.

Juan Li1, Shan-Yu Chen2, Hong-Hui Liu1, Xiao-Dong Yin1, Long-Ting Cao1, Jian-Hua Xu2, Xiao-Mei Li3, Dong-Qing Ye1, Jing Wang4.   

Abstract

BACKGROUND: This study aims to evaluate whether the Vitamin D receptor (VDR) gene polymorphisms were associated with systemic sclerosis (SSc) in a Chinese Han population.
METHODS: Using a hospital-based case-control study including 100 SSc patients and 100 healthy controls. Single nucleotide polymorphisms (SNPs) in the VDR region were genotyped by the improved multiplex ligase detection reaction (i MLDR) method. Haplotypes were also constructed after linkage disequilibrium (LD) analysis.
RESULTS: Eight SNPs (rs731236 (TaqI), rs2228570 (FokI), rs7975232 (ApaI), rs1544410 (BsmI), rs11574010 (Cdx2), rs739837 (BglI), rs757343 (Tru9I) and rs11168267) were included. There were significant differences between SSc patients and healthy individuals in ApaI and BglI genotype (both adjusted p = 0.008). Through the genotyping, significantly association of SSc were found for: dominant model of ApaI and BglI (both OR (95% CI) = 1.80 (1.03,3.16), p = 0.040). Furthermore, the elevation of erythrocyte sedimentation rate (ESR) had a higher percentage of BglI GT genotype frequency (p = 0.034) and dominant model of ApaI (p = 0.016) in SSc. There was high linkage disequilibrium was detected in BglI and ApaI polymorphisms (r2 = 1.0, D' = 1.0), Tru9I and rs11168267 (r2 = 0.926, D' = 0.969), respectively. No significant difference were found in these four haplotypes (all p >0.05). The correlation between VD levels and VDR gene polymorphisms was not statistically significant.
CONCLUSIONS: Our preliminary study indicates the ApaI and BglI genotype may possibly have a role in the pathogenesis of SSc patients. Dominant model of ApaI and BglI GT genotype frequency may be associated with the increased risk of ESR.
Copyright © 2019 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Polymorphism; Systemic sclerosis; VDR; Vitamin D receptor

Mesh:

Substances:

Year:  2019        PMID: 31678895     DOI: 10.1016/j.arcmed.2019.09.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  6 in total

1.  The Effect of ACTN3 and VDR Polymorphisms on Skeletal Muscle Performance in Axial Spondyloarthropathies.

Authors:  Isabel Pimenta; Hugo Mateus; Santiago Rodrigues-Manica; Rita Pinheiro-Torres; Agna Neto; Lúcia Domingues; Carolina Lage Crespo; Atlas Sardoo; Pedro Machado; Jaime C Branco; Susana N Silva; Fernando M Pimentel-Santos
Journal:  Front Genet       Date:  2021-08-11       Impact factor: 4.599

2.  Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.

Authors:  Paraskevi Chairta; Savvas Psarelis; Kyriaki Michailidou; Christiana Demetriou; Sofia Symeonidou; Paschalis Nicolaou; Kyproula Christodoulou
Journal:  Genet Test Mol Biomarkers       Date:  2020-04-21

Review 3.  Vitamin D's Effect on Immune Function.

Authors:  Pieter-Jan Martens; Conny Gysemans; Annemieke Verstuyf; And Chantal Mathieu
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

Review 4.  Vitamin D in Systemic Sclerosis: A Review.

Authors:  Mattia Perazzi; Enrico Gallina; Giulia Francesca Manfredi; Filippo Patrucco; Antonio Acquaviva; Donato Colangelo; Mario Pirisi; Mattia Bellan
Journal:  Nutrients       Date:  2022-09-21       Impact factor: 6.706

5.  Dualities of the vitamin D in systemic sclerosis: a systematic literature review.

Authors:  Laiana Schneider; Vanessa Hax; Odirlei Monticielo; Tamires Ferri Macedo; Roberta Kern Menna Barreto; Natália Aydos Marcondes; Rafael Chakr
Journal:  Adv Rheumatol       Date:  2021-06-09

Review 6.  Influence of Seasonal Vitamin D Changes on Clinical Manifestations of Rheumatoid Arthritis and Systemic Sclerosis.

Authors:  Maurizio Cutolo; Stefano Soldano; Alberto Sulli; Vanessa Smith; Emanuele Gotelli
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.